Host: Jacob Sands, MD <br>

  Guest: Mark Awad, MD, PhD <br>


  
    <p>Immunotherapy has led to impressive results, but when is it needed? Dr. Jacob Sands discusses the role of immunotherapy in managing lung cancer with Dr. Mark Awad, a thoracic medical oncologist, Clinical Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School.­</p>

Host: Jacob Sands, MD Guest: Mark Awad, MD, PhD Immunotherapy has led to impressive results, but when is it needed? Dr. Jacob Sands discusses the role of immunotherapy in managing lung cancer with Dr. Mark Awad, a thoracic medical oncologist, Clinical Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School.­

Share Investigating Immunotherapy & Its Role in NSCLC

Sign up to save your podcasts

Investigating Immunotherapy & Its Role in NSCLC

Investigating Immunotherapy & Its Role in NSCLC